Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
Frontiers | Hyperthermia combined with immune checkpoint inhibitor therapy in the treatment of primary and metastatic tumors
Integrative analysis of gut microbiome and host transcriptomes reveals associations between treatment outcomes and immunotherapy‐induced colitis - Sakurai - 2022 - Molecular Oncology - Wiley Online Library
Frontiers | Association between immune-related adverse events and the efficacy of PD-1 inhibitors in advanced esophageal cancer
Frontiers | Interaction between gut microbiota and immune checkpoint inhibitor-related colitis
Benjamin Terrier on Twitter: "Immune-related adverse events (irAE) of immune checkpoint inhibitors - By Antoine Briantais @A_Briantais (Fellow in Internal Medicine, Marseille, France) #irAE #immunecheckpoint #ICI #InternistAcademy 2019 https://t.co ...
Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy - Jing Lu, Linda Lee-Gabel, Michelle C Nadeau, Thomas M Ferencz, Scott A Soefje, 2015
T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma | Nature Medicine
![PDF] Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors](https://i1.rgstatic.net/publication/335905184_Variation_in_the_Assessment_of_Immune-Related_Adverse_Event_Occurrence_Grade_and_Timing_in_Patients_Receiving_Immune_Checkpoint_Inhibitors/links/5d82da2f92851ceb791417a8/largepreview.png "PDF] Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors")
PDF] Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors
Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors. - Abstract - Europe PMC
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy - Curry - 2017 - Journal of Cutaneous Pathology - Wiley Online Library
PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective | Molecular Pharmaceutics
Cancers | Free Full-Text | Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma
Diagnostics | Free Full-Text | Immune-Related Uncommon Adverse Events in Patients with Cancer Treated with Immunotherapy
The contribution of skeletal muscle to cancer immunotherapy: a focus on muscle function, inflammation and microbiota - ScienceDirect
Plasmacytic cutaneous pathology: A review - Walsh - 2019 - Journal of Cutaneous Pathology - Wiley Online Library
Irae - F*** the Human Rights - YouTube
PDF) Nivolumab-associated acute glomerulonephritis: a case report and literature review
Cureus | Nivolumab-Induced Crescentic Immunoglobulin A Nephropathy With Henoch-Schonlein Purpura Features in a Patient Diagnosed With Hepatocellular Carcinoma
Abstracts presented at the 14th European Colorectal Congress (#ECCStGallen), 29.11.2020–2.12.2020, St.Gallen, Switzerland | SpringerLink
Association Between the Occurrence and Spectrum of Immune-Related Adverse Events and Efficacy of Pembrolizumab in Asian Patients With Advanced Urothelial Cancer: Multicenter Retrospective Analyses and Systematic Literature Review - Clinical ...
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade | Nature Communications
Immune checkpoint inhibitors in cancer therapy: a focus on T‐regulatory cells - Sasidharan Nair - 2018 - Immunology & Cell Biology - Wiley Online Library
Journal of Medicinal Chemistry | Vol 52, No 22
